TELA Bio(R) Announces Plans to Launch OviTex(R) Reinforced BioScaffolds in Europe

Distinct class of surgical implants for hernia procedures to launch in Europe MALVERN, Pa., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization o... Devices, Surgery, Product Launch TELA Bio, OviTex, Reinforced BioScaffold, hernia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Marketing